MedPath

Effect of Turmeric supplementation on type 2 Diabetic patients and subjects with impaired fasting glucose.

Not Applicable
Recruiting
Conditions
Health Condition 1: null- Type 2 Diabetic Patients
Registration Number
CTRI/2012/02/002442
Lead Sponsor
JIPMER Intramural fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

The diabetic patients those who were under metformin treatment (500mg twice a day) minimum for two years were included in the study.

Exclusion Criteria

Patients with diabetic complications include retinopathy, nephropathy, neuropathy, hypertension, and other diseases

Patients on insulin treatment and hypoglycemic treatment were excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Turmeric supplementation reduces insulin resistance by combating oxidative stress and inflammationTimepoint: Four weeks (one month)
Secondary Outcome Measures
NameTimeMethod
Turmeric reduces lipid profile thereby reduces the risk of developing cardiovascular riskTimepoint: Four weeks (one month)
© Copyright 2025. All Rights Reserved by MedPath